STOCK TITAN

The Gabelli Healthcare & Wellness Trust (GRX) Form 4 Filings

GRX NYSE

Here are the Form 4 insider transactions from The Gabelli Healthcare & Wellness Trust (GRX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow GRX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GRX filings page.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) had a reported purchase of 1,056 common shares at $10.21 per share on November 18, 2026. The securities were held by funds and accounts for which Saba Capital Management, L.P., a ten percent owner, serves as investment manager; those holdings totaled 2,197,294 shares after the purchase. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported an indirect purchase of 200 common shares on November 16, 2026, at $10.40 per share. The shares were held by funds and/or accounts for which Saba Capital serves as investment manager; the reported resulting position was 2,196,238 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., identified as a 10% owner, purchased 300 common shares on November 13, 2026, at $10.40 per share. The shares are held by funds and/or accounts for which Saba Capital Management serves as investment manager. The reported resulting indirect position was 2,196,038 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported an indirect purchase of 8,916 common shares on November 5, 2026, at $10.44 per share. Saba Capital Management, L.P., identified as a 10% owner, serves as investment manager for the funds and/or accounts holding the shares; those funds and accounts reported 2,195,738 shares following the purchase. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported an indirect purchase of 700 shares by funds and accounts for which Saba Capital Management, L.P., a ten percent owner, serves as investment manager. The purchase was reported on November 4, 2026, at $10.4300 per share; the post-transaction holding was reported as 2,186,822 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) common stock was purchased indirectly by funds and/or accounts for which Saba Capital Management, L.P., a 10% owner, serves as investment manager: 100 shares at $10.18 per share on November 3, 2026. The reported indirect holdings following the transaction were 2,186,122 shares. Boaz R. Weinstein serves as the managing member of Saba Capital Management GP, LLC, the general partner of Saba Capital Management, L.P.; no Rule 10b5-1 plan is reported.

Rhea-AI Summary

Funds and accounts managed by Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), purchased 1,201 common shares on November 2, 2026, at $10.15 per share. The reported resulting position was 2,186,022 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, made an indirect purchase of 10,196 common shares on October 30, 2026, at $10.13 per share. The securities are held by funds and/or accounts for which Saba Capital Management, L.P. serves as investment manager. The reported position after the purchase was 2,184,821 common shares. The purchase was not reported under a Rule 10b5-1 plan.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that funds and/or accounts for which ten percent owner Saba Capital Management, L.P. serves as investment manager purchased 500 shares on October 29, 2026, at $10.09 per share. The purchase was reported as indirect, with reported holdings of 2,174,625 shares following the transaction. Boaz R. Weinstein is identified as managing member of Saba Capital Management GP, LLC, the general partner of Saba Capital Management, L.P. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that funds and accounts for which Saba Capital Management, L.P., a ten percent owner, serves as investment manager purchased 300 common shares on October 27, 2026, at $9.99 per share. The reported resulting holdings were 2,174,125 shares. No Rule 10b5-1 plan is reported for the purchase.

Rhea-AI Summary

Funds and/or accounts for which Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), serves as investment manager purchased 1,284 common shares at $10 per share on October 26, 2026. Their reported indirect position after the purchase was 2,173,825 shares. Boaz R. Weinstein is identified as managing member of Saba Capital Management GP, LLC, the general partner of Saba Capital Management, L.P.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, indirectly purchased 200 shares of common stock at $9.88 per share on October 15, 2026. The reported position after the purchase was 2,172,541 shares. The transaction is classified as an indirect holding, and no Rule 10b5-1 plan is reported.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that its ten percent owner, Saba Capital Management, L.P., indirectly purchased 400 shares on October 8, 2026, at $9.40 per share. Following the purchase, Saba Capital Management, L.P. reported holdings of 2,172,341 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reports that its ten percent owner, Saba Capital Management, L.P., indirectly purchased 2,955 shares of Common Stock on October 7, 2026, at $9.43 per share. The reported position following the purchase was 2,171,941 shares, also held indirectly.

Rhea-AI Summary

Saba Capital Management, L.P., identified as a 10% owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported an indirect purchase of 4,439 common shares on October 6, 2026, at $9.41 per share. Holdings following the transaction were 2,168,986 shares. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

For Gabelli Healthcare & WellnessRx Trust (GRX), Saba Capital Management, L.P., a ten percent owner, reported an indirect purchase of 1,775 common shares on October 5, 2026, at $9.38 per share. The purchase was described as an open-market or private transaction.

Saba Capital Management, L.P. reported holdings of 2,164,547 shares following the transaction. No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) had two indirect common-stock purchases reported by its 10% owner, Saba Capital Management, L.P.: 5,720 shares at $9.4100 per share on October 1, 2026, and 500 shares at $9.3500 per share on October 2, 2026. The reported purchases total 6,220 shares; no Rule 10b5-1 plan is reported.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that its 10% owner, Saba Capital Management, L.P., indirectly purchased 519 common shares on September 30, 2026, at $9.52 per share. The reported indirect position following the purchase was 2,156,552 shares. The Rule 10b5-1 checkbox was unchecked.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported an insider filing showing that Saba Capital Management, L.P., a ten percent owner, purchased 400 shares of Common Stock on September 11, 2026 in an open-market or private transaction at $9.71 per share, bringing its indirect holdings to 2,156,033 shares.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that major shareholder Saba Capital Management, L.P., a ten percent owner, purchased 500 shares of common stock on September 3, 2026, at $10.08 per share in an open-market or private transaction, held indirectly. Following this trade, Saba Capital’s reported indirect holdings rose to 2,155,633 shares. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, purchased 4,340 shares of common stock on August 27, 2026, in an open-market or private transaction at $10.05 per share. Following this indirect ownership purchase, Saba Capital Management reports holding 2,155,133 common shares of GRX.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) reported that Saba Capital Management, L.P., a ten percent owner, purchased 7,087 shares of Common Stock in an open-market or private transaction on 2026-08-21 at $10.13 per share. After this transaction, Saba Capital Management, L.P. indirectly holds 2,150,793 shares of GRX Common Stock.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust (GRX) had a Form 4 filed reporting that Saba Capital Management, L.P., a ten percent owner, purchased 24,102 shares of GRX common stock on 2026-08-19 at $10.13 per share in an open-market or private transaction. Following this buy, Saba’s indirectly held position is reported as 2,143,706 shares. The Rule 10b5-1 checkbox was not marked, indicating the trade was not reported as pursuant to a pre-arranged trading plan.

Rhea-AI Summary

Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported a purchase of common stock. On 2026-08-14 it bought 1,203 shares at $9.86 per share in an open market or private transaction, bringing its reported indirect holdings to 2,119,604 shares.

Rhea-AI Summary

Saba Capital Management, L.P., a ten percent owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported purchasing 200 shares of common stock on 2026-08-11 at $9.93 per share in an open market or private transaction. Following this indirect acquisition, Saba Capital’s reported holdings increased to 2,118,401 shares of GRX common stock.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust reported insider activity involving entities associated with Mario J. Gabelli. On January 12, 2026, GGCP, Inc. purchased 3,800 common shares at $9.58 per share, bringing its reported holdings to 316,026 shares. On the same date, Associated Capital Group, Inc. purchased 1,010 common shares at $9.58, bringing its reported holdings to 10,000 shares.

The form also lists 239,425 common shares held directly, plus indirect holdings of 6,380 shares through GPJ Retirement Partners and 3,000 shares in trust accounts. Mario J. Gabelli is a director of the trust and a control person of its adviser, and the disclosure states he disclaims beneficial ownership of shares held by these entities in excess of his indirect pecuniary interest.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust reported an insider transaction linked to Mario J. Gabelli, a director and control person of the adviser. On January 8, 2026, Associated Capital Group, Inc., an entity associated with him, purchased 990 common shares at $9.58 per share, bringing its reported indirect position to 8,990 shares.

Following this update, Mario J. Gabelli is reported as beneficially owning 239,425 common shares directly, and additional indirect holdings of 312,226 shares through GGCP, Inc., 6,380 shares through GPJ Retirement Partners, LLC, and 3,000 shares through a trust account, with footnotes stating he disclaims beneficial ownership beyond his indirect pecuniary interest in these entities.

Rhea-AI Summary

Mario J. Gabelli, a director, 10% owner and control person of the adviser to Gabelli Healthcare & WellnessRx Trust, reported multiple transactions in the trust’s Series E Cumulative Preferred Shares dated 12/26/2025. The filing shows open-market or similar purchases of 1,000,000 Series E shares at $10 per share held directly, plus additional purchases of 500,000 shares through Associated Capital Group, Inc., 200,000 shares through GGCP, Inc., and 100,000 shares through MJG Associates, each at $10 per share.

The report also discloses a disposition of 200,000 Series E shares at $10 per share, described as shares surrendered under a contractual “Right to Put to the Fund” for up to 100% of the outstanding Series E preferred. Gabelli disclaims beneficial ownership of shares held by Associated Capital Group and GGCP beyond his indirect pecuniary interest.

Rhea-AI Summary

Mario J. Gabelli reported insider transactions in Gabelli Healthcare & WellnessRx Trust Series G Cumulative Preferred Shares. On 12/26/2025, affiliates recorded a purchase of 100,000 Series G shares at $10 per share through GAMCO Investors, Inc., bringing GAMCO’s indirectly held amount to 500,000 shares. On the same date, 500,000 Series G shares were surrendered at $10 per share by Associated Capital Group, Inc. in connection with a right to put up to 100% of the outstanding Series G preferred shares to the fund, after which AC was shown with 1,500,000 shares. The filing notes Gabelli is a director, 10% owner, and control person of the adviser, and that he disclaims beneficial ownership beyond his indirect pecuniary interest in both GAMCO and AC holdings.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust reporting persons associated with Saba Capital Management, L.P. disclosed open-market purchases of the fund's common stock.

On December 16, 2025, they purchased 11,312 common shares at $9.37 per share, and on December 17, 2025 they purchased an additional 4,084 shares at $9.36. Following these transactions, they beneficially owned 2,118,201 shares of common stock held indirectly.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust director and adviser control person Mario J. Gabelli reported an open-market purchase of common shares. On 12/03/2025 he bought 2,500 common shares at a price of $9.6877 per share, a transaction reported as a purchase. Following this trade, he directly holds 239,425 common shares.

In addition to his direct holdings, the filing lists indirect beneficial ownership positions: 312,226 shares through GGCP, Inc., 8,000 shares through Associated Capital Group, Inc., 6,380 shares through GPJ Retirement Partners, and 3,000 shares in a trust account established by Mr. Gabelli. For several of these entities he notes that he owns less than 100% and disclaims beneficial ownership of shares beyond his indirect pecuniary interest.

Rhea-AI Summary

Gabelli Healthcare & WellnessRx Trust director reports multiple share sales. A director of Gabelli Healthcare & WellnessRx Trust (ticker GRX) filed a Form 4 disclosing a series of open-market sales of common shares, par value $0.001, during August, September, and October 2025. Reported transactions include several sales of 2,000 shares and smaller blocks of 200 to 1,000 shares at prices around $9.1 to $9.5 per share. After these transactions, the reporting person directly beneficially owned 2,185 common shares.

Rhea-AI Summary

Saba Capital Management, L.P., a 10% owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported a recent insider purchase. On 11/25/2025, the firm bought 14,451 shares of GRX common stock in an open-market transaction coded "P" at a price of $9.62 per share. After this trade, Saba Capital Management, L.P. indirectly beneficially owned 2,102,805 GRX shares, as reported on this Form 4.